Saints Capital Everest LP

All filings by Saints Capital Everest LP on record concern REVA Medical, Inc. Between 16 December 2010 and 18 March 2012, the trades on record add up to 10 filings.

Market trades split into 1 purchase (€76k) and 2 sales (€11.8M). Taken together, the sales exceed the purchases by €11.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants. Since January 2016: no purchases and 1 sale on the market.

Most recently, on 25 May 2016, the filings show an open-market sale worth €6.4M in REVA Medical, Inc. The clock since the last published purchase (21 December 2010) now reads 5,802 days. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.